- Patent Title: Prevention and treatment of complement-associated eye conditions
-
Application No.: US13554787Application Date: 2012-07-20
-
Publication No.: US08497094B2Publication Date: 2013-07-30
- Inventor: Philip Hass , Yin Jianping , Kenneth Katschke, Jr. , Micah Steffek , Christian Wiesmann , Menno Van Lookeren Campagne
- Applicant: Philip Hass , Yin Jianping , Kenneth Katschke, Jr. , Micah Steffek , Christian Wiesmann , Menno Van Lookeren Campagne
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Arnold & Porter LLP
- Agent Bonny Yeung; Victoria L. Boyd
- Main IPC: C12P21/06
- IPC: C12P21/06 ; C12N5/10 ; C12N15/63 ; C07H21/00
Abstract:
The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of Factor D antagonists.
Public/Granted literature
- US20130052685A1 PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS Public/Granted day:2013-02-28
Information query
